Why Rapamycin Has Longevity Researchers Excited
Rapamycin (sirolimus) is an FDA-approved immunosuppressant drug originally used in organ transplant patients. It became a longevity research darling when scientists discovered it extends lifespan in mice — not by a small margin, but by 9–14%. It is one of the few compounds that has reproducibly extended lifespan in multiple mammalian species when started in middle age.
The mechanism is mTOR inhibition. mTOR (mechanistic target of rapamycin) is a master nutrient-sensing pathway that, when chronically activated, accelerates cellular aging. Inhibiting mTOR promotes autophagy — the cellular recycling process that clears damaged proteins and organelles — and slows some age-related cellular changes.
The problem: rapamycin requires a prescription, has significant immunosuppressive effects at standard doses, and the optimal dosing protocol for longevity (as opposed to transplant use) is still being studied in clinical trials.
This creates genuine interest in over-the-counter compounds that influence the same pathways.
Related: Want to put this into practice? Try our Supplement Stack Audit to get started, and check out Anti-Aging Supplements Ranked by Research for more context.
The mTOR Pathway: What OTC Options Can Do
No OTC supplement inhibits mTOR with the potency of rapamycin. That is worth stating clearly. What some compounds may do is modulate upstream signals that feed into mTOR activation — reducing chronic mTOR activity without the direct inhibition rapamycin achieves.
The most actionable upstream levers are:
- AMPK activation — AMPK and mTOR have a reciprocal relationship. Activating AMPK tends to inhibit mTOR.
- Autophagy induction — independently supporting the cellular recycling process rapamycin promotes
- NAD+ support — sirtuins (activated by NAD+) work in parallel longevity pathways
- Senolytic activity — clearing senescent cells, a complementary approach to mTOR inhibition
The OTC Compounds with the Best Evidence
Berberine — The AMPK Activator
Berberine activates AMPK through multiple mechanisms, making it one of the most researched and most accessible mTOR-adjacent compounds available over the counter. As AMPK activation indirectly suppresses mTOR signaling, berberine has been called a partial rapamycin mimic by some researchers.
Human evidence: substantial trials for blood glucose and lipid management (AMPK mediates both). Longevity-specific human trials do not yet exist, but the mechanistic overlap is real.
Dose: 500mg twice daily with meals. Cycling (3 months on, 1 month off) is commonly recommended to maintain sensitivity.
Berberine has clinically meaningful effects on blood glucose and may interact with diabetes medications. If you take metformin or insulin, discuss berberine use with your doctor before adding it.
Quercetin — Senolytic and mTOR Modulator
Quercetin is a flavonoid with two distinct longevity-relevant actions. First, it has demonstrated senolytic activity — it helps clear senescent "zombie" cells that accumulate with age and drive chronic inflammation. Second, it modulates the PI3K/AKT pathway that feeds into mTOR activation.
Quercetin's challenge is poor bioavailability. Standard quercetin is poorly absorbed; quercetin phytosome (complexed with phospholipids) or EMIQ (enzymatically modified) forms substantially improve this.
Dose for senolytic use: 500–1,000mg of a bioavailable form, typically used in a 2-day "pulse" protocol (not daily) following the dasatinib + quercetin research methodology. Daily low-dose use is a different application.
Spermidine — Autophagy Induction
Spermidine is a polyamine compound that declines with age in human tissue. It is found in foods (wheat germ, soybeans, aged cheese) and is available as a supplement. Its primary longevity mechanism is autophagy induction — through a pathway distinct from but parallel to rapamycin's mTOR inhibition.
Human evidence includes an observational study showing correlation between dietary spermidine intake and reduced all-cause mortality. A small RCT in older adults with subjective cognitive decline found improvements in cognitive testing after 12 months of spermidine supplementation.
Spermidine is one of the few longevity supplements with a human randomized trial showing a functional outcome (cognitive improvement). The study is small and needs replication, but the evidence quality is above average for this category.
Dose: 1.2mg daily of spermidine (from wheat germ extract), which is the dose used in clinical research.
Resveratrol — The Controversial Sirtuin Activator
Resveratrol activated sirtuins in early research and generated enormous excitement about a red-wine compound extending lifespan. Subsequent work complicated this picture significantly — the original sirtuin activation findings were partially retracted, and large human trials have been disappointing for most outcomes.
Resveratrol's status today: mechanistically interesting, but the human evidence has not delivered on early promise. Still included here because it is widely discussed and has NAD+-adjacent sirtuin biology, but it sits at the bottom of the evidence ranking for this class.
If using: 250–500mg of trans-resveratrol (the active form) with a fatty meal. Combined with pterostilbene (a more bioavailable analogue) in some formulations.
Pros
- +Several compounds target genuinely relevant longevity pathways
- +Berberine and quercetin have strong supporting human evidence for related outcomes
- +Spermidine has early human trial data showing functional cognitive benefits
- +These compounds are far safer than rapamycin's immunosuppressive profile
- +Some (berberine) have additional near-term metabolic benefits beyond longevity
Cons
- -No OTC compound matches rapamycin's potency as an mTOR inhibitor
- -Human longevity trial evidence is largely absent — most is mechanistic or animal data
- -Effect sizes are likely small compared to the magnitude of lifestyle interventions
- -Bioavailability problems undermine many compounds if not addressed in the formulation
- -Longevity benefits (if real) may take decades to manifest — difficult to measure
What Actually Has the Best Evidence for Longevity
Before spending money on these compounds, it is worth noting that the interventions with the strongest human longevity evidence are not supplements:
- Aerobic exercise (VO2 max improvement is the strongest single predictor of lifespan)
- Resistance training (muscle mass preservation in aging)
- Sleep quality (7–9 hours reduces all-cause mortality risk)
- Caloric restriction or time-restricted eating (human evidence for metabolic benefits, longevity evidence in animals)
These interventions work through many of the same pathways (AMPK, autophagy, inflammation reduction) as the supplements above — and the human evidence for them is vastly more robust.
Tracking Your Longevity Stack
Be the first to try Prova
We're building an app to track whether longevity supplement tracking actually works. Join the waitlist.
Longevity outcomes are impossible to measure directly in any reasonable timeframe. What you can track are proxy biomarkers: fasting glucose, HbA1c, triglycerides, CRP (inflammation), and HRV (nervous system recovery). These are downstream of the pathways these compounds target. Run 3-month experiments tracking relevant biomarkers before and after adding each compound.
The Bottom Line
OTC rapamycin alternatives cannot replicate rapamycin's direct mTOR inhibition, but several compounds — berberine, quercetin, spermidine — target meaningfully overlapping pathways with reasonably solid evidence. They are safer, accessible without a prescription, and worth considering as part of a comprehensive longevity stack. Combine them with the lifestyle interventions that have far stronger human evidence, and track proxy biomarkers rather than expecting to measure lifespan directly.